Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Dillon & Associates Inc.

Dillon & Associates Inc. increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 24,823 shares of the medical equipment provider’s stock after acquiring an additional 549 shares during the period. Intuitive Surgical makes up about 1.8% of Dillon & Associates Inc.’s investment portfolio, making the stock its 16th largest position. Dillon & Associates Inc.’s holdings in Intuitive Surgical were worth $12,958,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. M.E. Allison & CO. Inc. acquired a new position in Intuitive Surgical during the fourth quarter worth about $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical in the 4th quarter worth approximately $82,517,000. Sycomore Asset Management grew its position in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after purchasing an additional 4,079 shares in the last quarter. Exome Asset Management LLC raised its stake in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. lifted its holdings in shares of Intuitive Surgical by 5.6% in the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock valued at $5,138,000 after purchasing an additional 525 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares of the company’s stock, valued at approximately $2,607,925.28. This represents a 68.85 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction that occurred on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 33,754 shares of company stock worth $17,691,621. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Up 0.1 %

Shares of ISRG stock opened at $492.49 on Monday. The stock has a 50 day moving average of $562.24 and a two-hundred day moving average of $532.03. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The company has a market capitalization of $175.41 billion, a P/E ratio of 76.83, a P/E/G ratio of 5.85 and a beta of 1.43.

Wall Street Analyst Weigh In

Several research firms recently weighed in on ISRG. Erste Group Bank lowered Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Leerink Partners raised their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Robert W. Baird lowered their price objective on shares of Intuitive Surgical from $707.00 to $600.00 and set an “outperform” rating on the stock in a research report on Tuesday, March 18th. BTIG Research increased their target price on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Finally, Truist Financial lowered their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a report on Monday, March 17th. One research analyst has rated the stock with a sell rating, five have given a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $611.86.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.